We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+25.08%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.97B
AUM Growth
+$1.75B
(+28%)
Cap. Flow
+$349M
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
26.82%
Holding
643
New
25
Increased
368
Reduced
201
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$64.9M |
| 2 |
Microsoft
MSFT
|
+$13.9M |
| 3 |
Amazon
AMZN
|
+$11.6M |
| 4 |
AbbVie
ABBV
|
+$9.54M |
| 5 |
Illinois Tool Works
ITW
|
+$8.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$19.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$16.2M |
| 3 |
Eli Lilly
LLY
|
+$13M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$5.8M |
| 5 |
Bank of America
BAC
|
+$3.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.9% |
| 2 | Healthcare | 14.53% |
| 3 | Financials | 12.89% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
CME Group
CME
$94.4B
| $16.7M | 0.21% |
102,922
+3,900
| +4% | +$699K |
|
|
102
Illinois Tool Works
ITW
$84.9B
| $16.4M | 0.21% |
94,057
+54,516
| +138% | +$8.9M |
|
103
Chubb
CB
$134B
| $16.4M | 0.21% |
129,353
+3,100
| +2% | +$359K |
|
|
FISV
104
Fiserv Inc
FISV
$29.7B
| $16.4M | 0.21% |
167,769
+8,800
| +6% | +$886K |
|
105
Illumina
ILMN
$30.7B
| $16.2M | 0.2% |
44,921
+2,270
| +5% | +$730K |
|
106
ConocoPhillips
COP
$144B
| $15.9M | 0.2% |
377,576
+49,800
| +15% | +$2.01M |
|
107
Humana
HUM
$43.5B
| $15.8M | 0.2% |
40,838
+3,480
| +9% | +$1.3M |
|
108
Ecolab
ECL
$79.7B
| $15.8M | 0.2% |
79,424
+592
| +0.8% | +$115K |
|
109
Autodesk
ADSK
$50.1B
| $15.5M | 0.19% |
64,898
+800
| +1% | +$157K |
|
110
Intercontinental Exchange
ICE
$83.8B
| $15.5M | 0.19% |
168,721
+19,172
| +13% | +$1.76M |
|
111
Mercado Libre
MELI
$95.7B
| $15.3M | 0.19% |
15,494
| – | – |
|
112
Global Payments
GPN
$24.1B
| $15M | 0.19% |
88,410
+2,733
| +3% | +$455K |
|
113
Consolidated Edison
ED
$40B
| $14.8M | 0.19% |
205,999
-14,400
| -7% | -$1.11M |
|
114
Sherwin-Williams
SHW
$87.8B
| $14.8M | 0.19% |
76,848
+1,800
| +2% | +$325K |
|
115
US Bancorp
USB
$100B
| $14.7M | 0.18% |
397,983
-38,216
| -9% | -$1.36M |
|
116
Progressive
PGR
$123B
| $14.6M | 0.18% |
182,427
+16,900
| +10% | +$1.32M |
|
117
Truist Financial
TFC
$64.3B
| $14.2M | 0.18% |
379,312
-5,800
| -2% | -$209K |
|
118
Blackstone
BX
$110B
| $14.2M | 0.18% |
250,600
+14,600
| +6% | +$768K |
|
119
Sempra
SRE
$56.6B
| $14.1M | 0.18% |
239,896
-9,200
| -4% | -$565K |
|
120
Biogen
BIIB
$30.8B
| $14M | 0.18% |
52,221
+700
| +1% | +$210K |
|
121
Boston Scientific
BSX
$71.1B
| $14M | 0.18% |
397,485
+16,800
| +4% | +$605K |
|
122
Dollar General
DG
$28.1B
| $13.9M | 0.17% |
72,903
+3,700
| +5% | +$670K |
|
123
Moody's
MCO
$83.8B
| $13.8M | 0.17% |
50,394
+3,500
| +7% | +$889K |
|
124
Deere & Co
DE
$167B
| $13.8M | 0.17% |
87,581
+7,500
| +9% | +$1.09M |
|
125
Aon
AON
$75.7B
| $13.8M | 0.17% |
71,456
+3,400
| +5% | +$634K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q2 2020 Portfolio in Review
As of Q2 2020, Fjarde Ap-fonden held 643 positions worth $7.97B, up 28% from $6.21B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fjarde Ap-fonden deployed $349M of net new capital in Q2 2020, opening 25 new positions and adding to 368 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 931,000 shares worth $67.3M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $19.6M trimmed.
- Fjarde Ap-fonden's largest Q2 2020 buy was iShares MSCI USA Value Factor ETF: 931,000 shares worth $67.3M.
- Fjarde Ap-fonden added most to Microsoft in Q2 2020, an estimated $13.9M increase.
- Fjarde Ap-fonden's biggest Q2 2020 reduction was ExxonMobil, cutting an estimated $19.6M.
- Fjarde Ap-fonden fully exited Allergan plc in Q2 2020, selling an estimated $16.2M.
- Fjarde Ap-fonden's ten largest holdings make up 27% of its $7.97B portfolio in Q2 2020.
- Fjarde Ap-fonden opened 25 new positions and closed 37 in Q2 2020.
- Fjarde Ap-fonden's portfolio value rose 28% quarter-over-quarter to $7.97B.
Based on Fjarde Ap-fonden's 13F filing for Q2 2020, filed 13 Aug 2020.